سیویلیکا را در شبکه های اجتماعی دنبال نمایید.

Seroprevalence of Hepatitis E Virus Infection among Patients with Acute Hepatitis Symptoms in Ahvaz, Iran

Publish Year: 1396
Type: Journal paper
Language: English
View: 202

This Paper With 8 Page And PDF Format Ready To Download

Export:

Link to this Paper:

Document National Code:

JR_JIML-5-1_002

Index date: 25 February 2023

Seroprevalence of Hepatitis E Virus Infection among Patients with Acute Hepatitis Symptoms in Ahvaz, Iran abstract

Background and Aims: Hepatitis E virus (HEV) is considered as one of the common causes of acute viral hepatitis in the world, particularly in the developing countries. It also causes fulminant hepatitis in pregnant women. Although HEV infection in Iran is endemic, there are numerous reports of epidemics caused by this infection in this part of the world. This study aimed to determine seroprevalence of HEV among patients with acute hepatitis symptoms in Ahvaz, Iran. Materials and Methods: In this cross-sectional study patients were selected  based on laboratory findings related to acute hepatitis including elevated serum bilirubin levels, markedly elevated levels of liver enzymes such as alanine aminotransferase, aspartate aminotransferase and mild increases in alkaline phosphatase activity.The plasma samples were tested for IgM/IgG Hepatitis E antibody (anti-HEV) using enzyme-linked immunosorbent assay. Results: Out of 241 study patients, 125 (51.9%) were male and 116 (48.1%) female. The mean age±SD was 31.53±17.17 years. The results indicated 27.4% prevalence of anti-HEV antibodies among patients with acute hepatitis in Ahvaz. Conclusions: In regard with the findings, HEV can play an important role in incidence of hepatitis. The study needs to be conducted in high-risk groups and in general populatios.

Seroprevalence of Hepatitis E Virus Infection among Patients with Acute Hepatitis Symptoms in Ahvaz, Iran Keywords:

Seroprevalence of Hepatitis E Virus Infection among Patients with Acute Hepatitis Symptoms in Ahvaz, Iran authors

Mehdi Parsa Nahad

Health Research Institute, Infectious and Tropical Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. ۲Department of Virology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Akbar Bavi

Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Milad Zandi

Department of Microbiology, Shahre Babak Azad Universiry, Shahre Babak, Iran.

Mehrab Nejati

Department of Microbiology, Golestan University of Medical Sciences, Gorgan, Iran.

Mehdi Rabie Rudsari

Department of Pharmacology and Toxicology, School of Pharmacy and Toxicology Research Center, Jundishapur University of Medical Sciences, Ahvaz, Iran.

Mohammad Amin Dehghani

Health Research Institute, Infectious and Tropical Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. ۲Department of Virology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Hadis Kiani

Health Research Institute, Infectious and Tropical Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. ۲Department of Virology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Ali Ramezani

Health Research Institute, Infectious and Tropical Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. ۲Department of Virology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Sara رمضانی

Department of Medical Microbiology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.

Nahid Omidi

Health Research Institute, Infectious and Tropical Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. ۲Department of Virology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Hojatolla Nikravesh

Department of Pharmacology and Toxicology, School of Pharmacy and Toxicology Research Center, Jundishapur University of Medical Sciences, Ahvaz, Iran.

Seyed Arash Moradpour

Departent of Pharmaceutics, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
. Meng XJ. Hepatitis E virus: animal reservoirs and zoonotic ...
. Navaneethan U, Al Mohajer M, Shata MT. Hepatitis E ...
. Joulaei H, Rudgari O, Motazedian N, Gorji-Makhsous S. Hepatitis ...
. Hughes JM, Wilson ME, Teshale EH, Hu DJ, Holmberg ...
. Yugo DM, Meng XJ. Hepatitis E virus: foodborne, waterborne ...
. Zaki ME, Aal AA, Badawy A, El-Deeb DR, El-Kheir ...
. Kumar S, Subhadra S, Singh B, Panda BK. Hepatitis ...
. Emerson SU, Purcell RH. Hepatitis E virus. Rev Med ...
. Shrestha AC, Faddy HM, Flower RL, Seed CR, Keller ...
. Chaudhry SA, Verma N, Koren G. Hepatitis E infection ...
. Kim JH, Nelson KE, Panzner U, Kasture Y, Labrique ...
. Bazerbachi F, Haffar S, Garg SK, Lake JR. Extra-hepatic ...
. Sridhar S, Lau SK, Woo PC. Hepatitis E: A ...
. Marano G, Vaglio S, Pupella S, Facco G, Bianchi ...
. Sepanlou SG, Rezvan H, Amini-Kafiabad S, Dayhim MR, Merat ...
. SeyedMohammad A, Fatameh A, MohammadReza G. Seroepidemiological Study of ...
. Asaei S, Ziyaeyan M, Moeini M, Jamalidoust M, Behzadi ...
. Taremi M, Gachkar L, MahmoudArabi S, Kheradpezhouh M, Khoshbaten ...
. Hosseini-Moghaddam SM, Zarei A, Alavian SM, Mansouri M. Hepatitis ...
. Keyvani H, Shamabadi MS, Najafifard S, Hajibeigi B, Fallahian ...
. Ghezeldasht SA, Miri R, Hedayatimoghadam M, Shamsian A, Bidkhori ...
. Assarehzadegan MA, Shakerinejad G, Amini A, Rezaee SR. Seroprevalence ...
. Behzadifar M, Lankarani KB, Abdi S, Mirghaed MT, Beyranvand ...
. Alavian SM, Fallahian F, Lankarani KB. Epidemiology of hepatitis ...
. Taherkhani R, Farshadpour F. Epidemiology of hepatitis E virus ...
. Taremi M, Alizadeh AH, Ardalan A, Ansari S, Zali ...
. Raoofi R, Nazer MR, Pournia Y. Sero- epidemiology of ...
. Mohebbi SR, Rostami Nejad M, Tahaei SM, Pourhoseingholi MA, ...
. Farshadpour F, Taherkhani R, Makvandi M. Prevalence of hepatitis ...
. Arabzadeh SA, Zahedi M, Molaei H, Aghaei AA. Seroepidemiology ...
. Chiu DM, Chan MC, Yeung A, Ngai KL, Chan ...
. Takeda H, Matsubayashi K, Sakata H, Sato S, Kato ...
. Hau CH, Hien TT, Tien NT, Khiem HB, Sac ...
. Fogeda M, Avellón A, Echevarria JM. Prevalence of specific ...
. Lu B, Zhao HL, Tian RG, Li HY, Zhan ...
. Faber MS, Wenzel JJ, Jilg W, Thamm M, Höhle ...
. Tadesse E, Metwally L, Alaa EL. High prevalence of ...
. Kaufmann A, Kenfak-Foguena A, André C, Canellini G, Bürgisser ...
. Ehteram H, Ramezani A, Eslamifar A, Sofian M, Banifazl ...
. Ataei B, Nokhodian Z, Javadi AA, Kassaian N, Shoaei ...
. Alavian SM. A Look at the Past History of ...
. Pérez-Gracia MT, García M, Suay B, Mateos-Lindemann ML. Current ...
. Bajpai M, Gupta E. Transfusion-transmitted hepatitis E: is screening ...
. Kamar N, Dalton HR, Abravanel F, Izopet J. Hepatitis ...
نمایش کامل مراجع